Status:
UNKNOWN
Impact of ERAS on Postoperative Nausea and Vomiting After Sleeve
Lead Sponsor:
Minia University
Conditions:
Nausea and Vomiting, Postoperative
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The use of bariatric surgery in the treatment of severe obesity has several benefits in terms of sustainable weight loss, improvements, or resolution of several metabolic comorbidities as well as impr...
Detailed Description
After obtaining Institutional Ethical Committee approval and written informed consent from the patients in each case, the ASA score, Simplified Apfel scores14 a measure of PONV risk, and duration of p...
Eligibility Criteria
Inclusion
- \* Age: 18-60 years
- Sex: Both sex
- ASA Physical Status: II, III.
- Body mass index: Between 40 and 60 kg/m2.
- Participants: Patients who are undergoing elective Sleeve Gastrectomy
Exclusion
- Patients with hypersensitivity or contraindication to haloperidol, dexamethasone, or ondansetron.
- Serious complications in the perioperative period (such as shock, cardiac arrest, hemorrhage, needing transfusion).
- Psychiatric disorder.
- History of migraine.
- Use of opioid, hormonal, anti-inflammatory, and antiemetic medication 24 h prior to surgery.
Key Trial Info
Start Date :
July 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05996887
Start Date
July 30 2023
End Date
January 1 2024
Last Update
August 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Minia University
Minya, Minya Governorate, Egypt, 61511